Tricor and Alli drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tricor and Alli. Common interactions include abdominal pain among females and multiple injuries among males.

The phase IV clinical study analyzes what interactions people who take Tricor and Alli have. It is created by eHealthMe based on reports of 11 people who take Tricor and Alli from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 15, 2022

11 people who take Tricor and Alli together, and have interactions are studied.


What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,123 Tricor users for its effectiveness, alternative drugs and more.

What is Alli?

Alli has active ingredients of orlistat. It is often used in weight loss. eHealthMe is studying from 22,127 Alli users for its effectiveness, alternative drugs and more.

Number of Tricor and Alli reports submitted per year:

Tricor and Alli drug interactions.

Common Tricor and Alli drug interactions by gender *:

female:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Blood glucose increased
  4. Constipation
  5. Diverticulitis
  6. Metrorrhagia
  7. Therapeutic response unexpected
  8. Vaginal haemorrhage
  9. Aortic arteriosclerosis
  10. Appendicitis

male:

  1. Multiple injuries
  2. Oedema peripheral
  3. Weight decreased
  4. Diabetes mellitus
  5. Oesophageal adenocarcinoma
  6. Oesophageal carcinoma
  7. Activated partial thromboplastin time prolonged
  8. Asthenia
  9. Atrial flutter
  10. Atrioventricular block first degree

Common Tricor and Alli drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Metrorrhagia
  2. Vaginal haemorrhage
  3. Hepatic failure
  4. Hyperglycaemia

50-59:

  1. Abdominal pain upper
  2. Appendicitis
  3. Gastrointestinal disorder
  4. Hepatic enzyme increased

60+:

  1. Blood glucose increased
  2. Atrial fibrillation
  3. Constipation
  4. Diverticulitis
  5. Dizziness
  6. Dyspnoea
  7. Nausea
  8. Right atrial dilatation
  9. Therapeutic response unexpected
  10. Diabetes mellitus

Common conditions people have *:

  1. Weight Loss: 3 people, 27.27%
  2. Weight Decreased: 1 person, 9.09%
  3. Dyslipidaemia (abnormal amount of lipids): 1 person, 9.09%
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tricor and Alli?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Tricor and Alli:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tricor interactions:

Browse all interactions between Tricor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate and orlistat (the active ingredients of Tricor and Alli, respectively), and Tricor and Alli (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Tricor and Alli.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: